not tagged
Kiniksa
[]
control of recurrent pericarditis (rp) requires a continued blockade of il-1 signaling for the duration of disease. come visit kiniksa's booth #1047 at #acr22 to learn about rp and a treatment option. 
Every Second Counts!

Kiniksa is a biopharmaceutical company focused on therapeutic medicines for immunological diseases with significant unmet medical need.